Skip to content Skip to global navigation Skip to main navigation Skip to sub navigation Skip to search

Assisted Reproductive Technology (ART)

Assisted reproductive technology (ART) is the application of laboratory or clinical technology to gametes (human egg or sperm) and/or embryos for the purposes of reproduction. All reproductive medicine units offering ART services should comply with the NHMRC Ethical Guidelines on the use of assisted reproductive technology in clinical practice and research (2007) (ART Guidelines).

The continued development of new technologies in ART means that ART remains a complex area, scientifically and ethically, for both clinical practice and research.


The NHMRC Ethical Guidelines on the use of assisted reproductive technology in clinical practice and research (2007) (ART Guidelines) deal with the ethical aspects of research and clinical practice of assisted reproductive technology. The document is divided into three parts. Part A provides background and introductory material. Part B provides ethical guidelines for the clinical practice of ART and Part C provides ethical guidelines for research. Part C of the guidelines is consistent with the Prohibition of Human Cloning for Reproduction Act 2002 (PHCR Act) and the Research Involving Human Embryos Act 2002 (RIHE Act) (collectively ‘the Acts’)

The ART Guidelines were issued in 2004 by the NHMRC and updated in 2007 to reflect amendments to the Acts.

The process of preparing the changes to the ART Guidelines in 2007 included comprehensive public consultation on part C of the guidelines, where 93 interested parties provided submissions.

The guidelines are primarily intended for ART practitioners, researchers, infertility clinic administrators, Human Research Ethics Committees and governments.

Use of Embryos in Research

The Research Involving Human Embryos Act 2002 (RIHE Act) requires that research on certain human embryos may only be conducted under a licence issued by the NHMRC Embryo Licensing Committee. The Licensing Committee must be satisfied that the research proposal has been assessed and approved by a Human Research Ethics Committee acting in compliance with the National Statement on Ethical Conduct in Human Research (2007) and the ART guidelines.

The RIHE Act distinguishes between embryos intended for transfer to a woman to achieve a pregnancy and embryos that have been deemed to be no longer needed in an ART program (‘excess ART embryos’). The Prohibition of Human Cloning for Reproduction Act 2002 (PHCR Act) and RIHE Act permit research on excess ART embryos, including those that are unsuitable for implantation, and embryos created by means other than by fertilisation of a human egg and human sperm. Consent from the donor must also be sought prior to use of excess ART embryos for research.

For any licensable activity the number of excess ART embryos, other embryos or human eggs should be restricted to that likely to be necessary to achieve the goals of the activity. Research proposals involving human embryos must not include any practices prohibited by the legislation.

Clinical Practice

Many aspects of clinical practice in ART raise ethical issues. The ART Guidelines cover activities including:

  • posthumous use of gametes
  • surrogacy
  • donor conception
  • sex selection; and
  • pre-implantation genetic diagnosis (PGD).

The role of the ART ethical guidelines in the regulation of ART

The Ethical guidelines on the use of assisted reproductive technology in clinical practice and research 2007 underpin the regulation of ART practice within Australia. Accreditation of ART treatment centres by the Reproductive Technology Accreditation Committee (RTAC) is the basis of a nationally consistent approach for overseeing ART clinical practice. RTAC accreditation requires ART treatment centres to comply with government laws and guidelines concerning the practice of ART. The ART Guidelines are included in this requirement. RTAC was established by the Fertility Society of Australia.

State and Territory ART legislation

Legislation in four states regulates ART - the Victorian Assisted Reproductive Treatment Act (2008), the New South Wales Assisted Reproductive Technology Act (2007), the South Australian Assisted Reproductive Treatment Act (1988) and the Western Australian Human Reproductive Technology Act (1991). Each of these pieces of legislation established a state regulatory body which issues licences to clinics that provide ART services. The ART Guidelines have been adopted through these pieces of legislation. When there are anomalies between the state acts and the guidelines, the state acts have precedence.

Sex Selection through Pre-implantation Genetic Diagnosis

The ART Guidelines restrict the use of PGD for sex selection in Australia. The guidelines state that sex selection (by whatever means) should not be undertaken except to reduce the risk of transmission of a serious genetic condition (see sections 11 and 12 of the ART Guidelines).

Review of the ART Guidelines

The Assisted Reproductive Technology (ART) Working Committee was established on 16 April 2013 to review Part B (on the ethical guidelines for the clinical practice of ART) of the ART Guidelines and provide draft ethical guidelines for consideration by the Australian Health Ethics Committee (AHEC).

Page last updated on 14 July 2014